Business

Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising

Updated 2026-07-21 11:55 UTC 2 sources Negative

Novo Nordisk has sued Eli Lilly, alleging that the latter’s GLP-1 advertising is misleading. The Danish company seeks a permanent injunction and corrective ads.

Coverage timeline — 2 articles
CNBC
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
2026-07-21 11:35 UTC
Deadline
European Audiovisual Entrepreneurs (EAVE), Storyboard Collective, WIFT Sweden and the European Women’s Audiovisual Network are among the first organizations that have joined Main Character, ARTEF’s pan-European search for unproduced feature fiction screenplays  Main Character was officia
2026-07-21 11:49 UTC
Share: Twitter / X LinkedIn